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Objective: Effective induction of human mesenchymal stem cell (hMSC) differentiation for regenerative
medicine applications remains a great challenge. While much research has studied hMSC activity during
differentiation, it is unclear whether pre-differentiation culture can modulate differentiation capacity.
We investigate the effect of glucose concentration in pre-differentiation/expansion culture on modu-
lating chondrogenic capacity of hMSCs, and explore the underlying molecular mechanism.
Design: The extent of chondrogenesis of hMSCs previously cultured with different concentrations of
glucose was evaluated. Transforming growth factor-beta (TGF-b) signaling molecules and protein kinase
C (PKC) were analyzed to identify the role of these molecules in the regulation of glucose on chondro-
genesis. In addition, hMSCs in high-glucose expansion culture were treated with the PKC inhibitor to
modulate the activity of PKC and TGF-b signaling molecules.
Results: High-glucose maintained hMSCs were less chondrogenic than low-glucose maintained cells
upon receiving differentiation signals. Interestingly, we found that high-glucose culture increased the
phosphorylation of PKC and expression of type II TGF-b receptor (TGFbRII) in pre-differentiation hMSCs.
However, low-glucose maintained hMSCs became more responsive to chondrogenic induction with
increased PKC activation and TGFbRII expression than high-glucose maintained hMSCs during differ-
entiation. Inhibiting the PKC activity of high-glucose maintained hMSCs during expansion culture
upregulated the TGFbRII expression of chondrogenic cell pellets, and enhanced chondrogenesis.
Conclusion: Our ﬁndings demonstrate the effect of glucose concentration on regulating the chondrogenic
capability of pre-differentiation hMSCs, and provide insight into the mechanism of how glucose
concentration regulates PKC and TGF-b signaling molecules to prime pre-differentiation hMSCs for
subsequent chondrogenesis.
 2012 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Human mesenchymal stem cells (hMSCs) represent a promising
component of regenerative medicine due to their extensive
proliferative capacity and multipotency1e3. The cells can be har-
vested from various tissues including bone marrow, fat or cord
blood4e6. With proper induction signals, hMSCs can differentiate
into osteoblasts, adipocytes or chondrocytes7. Previous studies have
reported that the differentiation capacity of hMSCs can be affectedto: W.-J. Li, Department of
dical Engineering, University
51, Madison, WI 53705, USA.
pmanner@u.washington.edu
s Research Society International. Pby a variety of factors, such as the chemical composition of culture
medium8,9.
Glucose concentration in culture medium has been shown to
have a profound effect on mesenchymal stem cell (MSC) differen-
tiation. For example, high-glucose culture medium enhances adi-
pogenesis of mouse bone marrow-derived MSCs10 and human
adipose tissue-derived MSCs11, compared to low-glucose medium.
Mineral deposition of MSCs during osteogenesis in high-glucose
medium is greater than that of MSCs in low-glucose medium12.
During chondrogenic induction, high-glucose medium enhances
chondrogenesis of chick mesenchymal cells, in comparison with
low-glucose medium13. These studies focused on investigating the
effect of glucose concentration on MSCs during cell differentiation.
However, it is likely that glucose concentration in hMSC expansion
culture can affect properties of pre-differentiation hMSCs, which
further changes their capacity of differentiation in response toublished by Elsevier Ltd. All rights reserved.
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expansion culture reduces the proliferation of hMSCs12,14, but
whether the differentiation capacity of hMSCs is regulated by
glucose concentration in expansion culture is not well-
characterized.
Activation of the transforming growth factor-beta (TGF-b)
signaling pathway is critical for chondrogenesis of hMSCs7,15e19.
TGF-b ligand binds to type II TGF-b receptor (TGFbRII) to form
a heterodimeric complex with type I TGF-b receptor (TGFbRI),
which phosphorylates downstream signaling molecule Smad2/3.
Phosphorylated Smad2/3 forms a heteromeric complex with
Smad4, acting as a transcriptional activator to regulate the activity
of TGF-b-responsive genes20,21, including Sox9 for chondro-
genesis22,23. Human MSCs transfected with the TGF-b124 or TGF-b2
gene25 have been shown to induce chondrogenesis with the
production of cartilage-related collagen type II.
Glucose has been shown to regulate the TGF-b signaling
pathway to modulate cell activity. High-glucose culture induces
hypertrophy of mouse embryonic ﬁbroblasts and rat kidney
epithelial cells through the upregulation of TGF-b signaling26. High-
glucose culture also modulates protein kinase C (PKC) activity to
upregulate the expression of TGF-b receptor expression of vascular
smooth muscle cells27,28.
In this study, we hypothesize that the glucose concentration in
hMSC expansion culture is able to modulate the chondrogenic
capacity of pre-differentiation hMSCs through the regulation of PKC
activity and TGF-b signaling. To test our hypothesis, hMSCs were
maintained in culture medium with different glucose concentra-
tions, and then induced in cell pellets for chondrogenesis. Cartilage-
related markers were analyzed to determine the extent of chon-
drogenesis of hMSCs between different groups. PKC activity and
TGF-b signaling were studied to identify the underlying
mechanism.
Materials and methods
Human MSC isolation and expansion
Human bone marrow-derived MSCs were isolated from femoral
heads of three patients between 25 and 50 years of age who
underwent total hip arthroplasty. The protocol was approved by the
Institutional Review Boards of University of Washington and
University of WisconsineMadison. Brieﬂy, 5 mL bone marrow was
harvested from the interior compartment of the femoral neck and
head, and thoroughly mixed with 30 mL Dulbecco’s Modiﬁed Eagle
Medium (DMEM) (Gibco, Carlsbad, CA). A syringe with an 18-gauge
needle was used to ﬁlter out bone debris. The bone marrow was
then centrifuged at 1,200 rpm for 5 min. After removing the
supernatant, the cell pellet was reconstituted in Hank’s Balanced
Salt Solution (Invitrogen, Carlsbad, CA), gently added into a conical
tube containing the Ficoll gradient solution (GE Health, Pittsburgh,
PA), and centrifuged at 600 g for 30 min. Mononuclear cells were
collected, reconstituted in culture medium composed of low-
glucose DMEM supplemented with 10% fetal bovine serum (FBS)
(Gibco) and antibiotics, plated in cell culture ﬂasks (Corning,
Corning, NY), and maintained at 37C in a humidiﬁed, 5% CO2
atmosphere. The cells were trypsinized using 0.05% trypsin/EDTA
(Gibco) after reaching 70e80% density conﬂuence, and re-plated at
a seeding density of 1,000 cells/cm2. Culture mediumwas replaced
every 3 days. At passage 2, hMSCs were divided into two inde-
pendent groups. One group was maintained in low-glucose
(1.0 mg/ml) DMEM and termed as low-glucose maintained cells
(LGMCs), and the other group was maintained in high-glucose
(4.5 mg/ml) DMEM and termed as high-glucose maintained cells
(HGMCs). Each assay was carried out using a single donor’s cellsand then repeated using different donors’ cells to conﬁrm the
reproducibility of experimental data. The results presented in this
study are representative results based on one donor’s cells.
Differentiation of different glucose concentration-maintained
hMSCs
Human MSCs were collected and made into high-density cell
pellets for chondrogenesis in a 96-well plate following the previ-
ously reportedmethodwithmodiﬁcations16. Brieﬂy, 250,000 hMSCs
were centrifuged in a well containing chondrogenic medium and
then maintained in a cell culture incubator. The chondrogenic
medium was composed of high-glucose DMEM, 1% ITSþ (BD
Biosciences, San Diego, CA), 0.9 mM sodium pyruvate, 50 mg/ml L-
ascorbic acid-2-phosphate, 107 M dexamethasone (SigmaeAldrich,
St. Louis, MO), and 40 mg/ml L-proline (Fluka, St. Louis, MO), sup-
plemented with 10 ng/ml TGF-b1 (R&D System, Minneapolis, MN).
For osteogenesis and adipogenesis, hMSCs were trypsinized and re-
plated in cell culture ﬂasks at the density of 5,000 or 10,000 cells/
cm2, respectively. The cells were induced in osteogenic medium
composed of low-glucose DMEM, 10% FBS, 50 mg/ml L-ascorbic acid-
2-phosphate, 107 M dexamethasone, and 10 mM b-glycer-
ophosphate (SigmaeAldrich), or in adipogenicmedium composed of
high-glucose DMEM, 10% FBS, 106 M dexamethasone, and 1 mg/ml
insulin (SigmaeAldrich). Culturemediumwas replaced every 3 days.
Flow cytometric analysis
Human MSCs were trypsinized and resuspended in ice-cold PBS
containing 1% bovine serum albumin and 0.1% sodium azide
(SigmaeAldrich). The cells were incubated with antibody against
cell surface antigens CD73, CD90, CD105, CD34, and CD45 (BD
Biosciences), ﬁxed with 1% paraformaldehyde solution, and then
analyzed by ﬂow cytometry (BD Biosciences). Data were analyzed
using the FlowJo software (TreeStar Inc., Ashland, OR).
Cell proliferation analysis
Human MSCs during expansion culture were harvested and
digested with Proteinase K (SigmaeAldrich) to extract DNA. Cell
proliferation was determined by measuring the total amount of
DNA using the PicoGreen Assay (Invitrogen).
RNA extraction and mRNA expression analysis
For quantitative reverse transcription polymerase chain reaction
(RTePCR) analysis, total RNA was isolated using the RNeasy Mini
Kit (Qiagen, Hilden, Germany). First-strand cDNA was reverse-
transcribed using the SuperScript III First-Strand Synthesis System
Kit (Invitrogen). Quantitative PCR analysis was performed using the
iQ SYBR Green Supermix (BioRad, Hercules, CA) with the primers
listed in Table I. The relative expression level of each target mRNA
was determined by referencing to the internal control glyceralde-
hyde 3-phosphate dehydrogenase (GAPDH) using the 2DCt method.
Histological analysis and glycosaminoglycan (GAG) quantiﬁcation
After 21 days of chondrogenic induction, cell pellets were ﬁxed
in 4% paraformaldehyde solution, dehydrated, inﬁltrated with
xylene, and embedded in parafﬁn. Eight-mm sections were cut
using a microtome, and then deparafﬁnized, rehydrated, and
stained using hematoxylin & eosin (H&E) and Alcian blue (Poly-
sciences, Warrington, PA).
Cell pellets were collected after 21 days of chondrogenic
induction and papain-digested at 60C. Total sulfated GAGwas then
Table I
List of quantitative RTePCR primers
Quantitative RTePCR primers
Accession Primer sequence
Sox9 NM_000346.3 F 50-TAAAGGCAACTCGTACCCAA-30
R 50-ATTCTCCATCATCCTCCACG-30
AGN NM_013227.2 F 50-CACGATGCCTTTCACCACGAC-30
R 50-TGCGGGTCAACAGTGCCTATC-30
Col II NM_001844.4 F 50-CCTCTGCGACGACATAATCT-30
R 50-CTCCTTTCTGTCCCTTTGGT-30
Col IX NM_001851.4 F 50-ATATCCCAGTGGACTGCCTG-30
R 50-GCTGCTGTTTGGAGACTTCC-30
Cbfa1 NM_004348.3 F 50-GGTTCCAGCAGGTAGCTGAG-30
R 50-AGACACCAAACTCCACAGCC-30
ALP NM_000478.3 F 50-CAAAGGCTTCTTCTTGCTGG-30
R 50-GGTCAGAGTGTCTTCCGAGG-30
OC NM_199173.3 F 50-GACTGTGACGAGTTGGCTGA-30
R 50-GGAAGAGGAAAGAAGGGTGC-30
PPARg2 NM_138711.3 F 50-ATGACAGCGACTTGGCAATA-30
R 50-GGCTTGTAGCAGGTTGTCTT-30
LPL NM_000237.2 F 50-AGGAGCATTACCCAGTGTCC-30
R 50-GGCTGTATCCCAAGAGATGGA-30
GAPDH NM_002046.3 F 50-CTCTCTGCTCCTCCTGTTCG-30
R 50-TTAAAAGCAGCCCTGGTGAC-30
T.-L. Tsai et al. / Osteoarthritis and Cartilage 21 (2013) 368e376370quantiﬁed by the 1,9-dimethylmethylene blue-based Blyscan GAG
Assay Kit (Biocolor, Carrickfergus, United Kingdom). The result was
normalizedwith the total amount of DNA determined separately by
the PicoGreen Assay.
Protein extraction and western blot analysis
Cell lysates were prepared using RIPA buffer composed of
50 mM TriseHCl (pH 7.5), 1% Nonidet P-40, 0.25% Na-deoxycholate,
150mMNaCl, 1 mM EDTA, and complete protease inhibitor cocktail
(Roche, Indianapolis, IN). After being centrifuged, the supernatant
was collected and the protein concentration was determined using
the BCA Protein Assay Kit (Pierce, Rockford, IL). A 50 mg protein
sample was loaded into each lane of a 10% polyacramide gel for
electrophoresis, and the separated proteins on the gel were then
transferred onto a polyvinylidene ﬂuoride membrane. Primary
antibodies for PKC pan-isoform (Pierce), phospho-PKC pan-isoform,
type I TGF-b receptor, type II TGF-b receptor, Smad3, phospho-
Smad3, and GAPDH (Cell Signaling, Danvers, MA) were used to
detect the target proteins. The immuno-detected membrane was
labeled with the secondary horseradish peroxidase-conjugated
antibody (Cell Signaling), visualized using the SuperSignal West
Pico Chemiluminescent Substrate (Pierce), and documented by
a digital image system (Kodak, Rochester, NY). The signal intensity
of each target protein expressed in gels was quantiﬁed by
measuring the densitometry and normalized to that of GAPDH.
PKC activity regulation
PKC activity was suppressed using the PKC inhibitor, Gö6983
(SigmaeAldrich). Speciﬁcally, hMSCs were cultured in high-glucose
culture medium with or without the addition of 70 nM of Gö6983
and analyzed for the effect of PKC activity on the regulation of
TGFbRII expression.
Soluble TGF-b1 quantiﬁcation
Culture medium was collected 15 min, 30 min, 1 h, 2 h and 4 h
after fresh medium change from hMSC expansion culture. TGF-b1
in the collected culture medium was quantiﬁed using the human-
speciﬁc TGF-b1 enzyme-linked immunosorbent assay (ELISA) Kit
(R&D Systems).Statistical analysis
Meanvalues of all quantitative assayswere calculated fromat least
three replicate samples. Error bars indicate 95% conﬁdence intervals
of the mean values. Replicate samples of each experimental group
were prepared from a single donor’s cells. The Student’s t-test was
used for statistical comparisons in all quantitative assays. A P-value of
less than 0.05 was considered statistically signiﬁcant.
Results
Human MSCs expanded in high-glucose culture are less
chondrogenic
We ﬁrst analyzed the phenotype of hMSCs by analyzing the
expression of cell surface antigens. The cells expressed CD73, CD90,
and CD105, but not CD34 and CD45 (Fig. S1), conﬁrming the
identity of hMSCs. To investigate the effect of glucose concentration
in hMSC pre-differentiation culture on modulating subsequent
chondrogenesis, hMSCs were cultured and expanded in high- or
low-glucose medium before chondrogenic induction [Fig. 1(A)].
Both HGMCs and LGMCs were elongated, spindle-shaped cells of
similar sizes [Fig. 1(B)]. However, HGMCs grew slower than LGMCs
[Fig. 1(C)]. After two cell passages, both cell types were made into
cell pellets and induced for chondrogenesis. Fig. 1(D) shows that at
day 9, the levels of mRNA expression of cartilage-related markers
Sox9 and aggrecan of HGMC pellets were signiﬁcantly down-
regulated, and at day 22, the expression levels of aggrecan and
collagen type II of HGMC pellets were also signiﬁcantly decreased,
compared to those of LGMC pellets. The expression level of collagen
type IX mRNA was comparable in both glucose concentration
culture. Histological analysis showed less intense Alcian blue
staining in HGMC pellets than in LGMC pellets [Fig. 1(E)]. Quanti-
ﬁcation of the total amount of GAG produced in the pellets showed
that HGMC pellets produced less GAG than LGMC pellets [Fig. 1(F)].
These collective results indicate that HGMCs are less effective than
LGMCs for chondrogenic induction, suggesting that the glucose
concentration prior to differentiation regulates the chondrogenic
capacity of hMSCs.
PKC activity, TGF-b receptor expression, and activation of
downstream signaling molecules during chondrogenesis are
different between HGMCs and LGMCs
We further tested whether the varying extent of chondrogenesis
between HGMCs and LGMCs is associated with the regulation of
TGF-b signaling. Thewestern blotting results showed that while the
TGFbRI expression levels of chondrogenic pellets were barely
detectable 12 h after induction (data not shown), the TGFbRII
expression of HGMC pellets was downregulated compared to that
of LGMC pellets [Fig. 2(A)]. The downstream signaling molecule
Smad3was less phosphorylated in HGMC pellets than that in LGMC
pellets during chondrogenesis [Fig. 2(A)]. These results suggest that
different glucose concentrations modulate hMSCs prior to differ-
entiation, thus altering the expression levels of TGFbRII of chon-
drogenic pellets and affecting the activation of downstream
molecules of TGF-b signaling during chondrogenesis.
To determine whether PKC is involved in the regulation of
glucose concentration of pre-differentiation culture, we compared
total and phosphorylated PKC in HGMC and LGMC pellets collected
12 h after initiation of chondrogenesis. The results showed that the
PKC phosphorylation of HGMC pellets was decreased in compar-
ison with that of LGMC pellets [Fig. 2(B)]. The regulation of PKC
activity by glucose concentration was consistent with the effect of
glucose concentration on the regulation of TGFbRII [Fig. 2(A)],
Fig. 1. Analysis of the chondrogenic capacity of HGMCs and LGMCs. A. Illustration of the experimental setup. hMSCs were maintained in expansion culture with low-glucose
(1.0 mg/ml) or high-glucose (4.5 mg/ml) DMEM. The cells were then trypsinized, made into chondrogenic pellets, and cultured in high-glucose chondrogenic medium. B.
Micrographs of hMSCs maintained in high- and low-glucose culture for two passages. Scale bar: 200 mm. C. Proliferation of HGMCs and LGMCs analyzed by quantifying the total DNA
amounts at Days 2, 4 and 8. The mean was calculated based on three replicate samples (n ¼ 3) for each group. D. Messenger RNA transcript levels of cartilage-related proteins of
HGMC and LGMC pellets chondrogenically induced and analyzed using quantitative RTePCR with GAPDH as a loading control. The mRNA levels of Sox9, aggrecan (AGN), collagen
types II (Col II) and IX (Col IX) were quantiﬁed at Days 9 and 22, and normalized to those of HGMC pellets at Day 9. The mean was calculated based on four replicate samples (n ¼ 4)
for each group. E. Histological analysis of HGMC and LGMC pellets after 21-day chondrogenic induction. The specimen sections were stained with H&E and Alcian blue. Scale bar:
500 mm. F. Quantiﬁcation of GAG in chondrogenic HGMC and LGMC pellets. The amount of GAG was determined and normalized with the total amount of DNA. The mean was
calculated based on six replicate samples (n ¼ 6) for each group.
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glucose concentration.
Glucose concentration surge is not a factor causing the different
regulation of PKC activity and TGF-b receptor between HGMC and
LGMC pellets
We tested whether the different PKC activity and TGFbRII
expression in HGMC and LGMC pellets was associated with a
glucose concentration surge from expansion culture to chondro-
genic culture. To compare with the experiment using the gold
standard protocol illustrated in Fig. 1(A), we set up another
experiment in which we induced chondrogenesis of HGMC pellets
in high-glucose medium, and chondrogenesis of LGMC pellets in
low-glucose medium [Fig. 2(C)]. The results showed that the
phosphorylation of PKC and TGFbRII expression level of HGMC
pellets were decreased compared to those of LGMC pellets
[Fig. 2(D)], similar to what is shown in Fig. 2(A and B). This suggests
that a glucose concentration surge is not involved in regulating PKC
activity and TGFbRII expression between HGMCs and LGMCs during
chondrogenesis.
Glucose concentration modulates PKC activity and TGFbRII
expression of pre-differentiation hMSCs, and changes their
responsiveness to chondrogenic induction
To investigate whether the effect of glucose on the regulation of
TGFbRII and PKC activity occurred prior to the initiation ofchondrogenesis, we analyzed HGMCs and LGMCs harvested from
expansion culture and chondrogenic pellets. Interestingly, the
expression levels of TGFbRII in both the cells from expansion culture
were lower than those from chondrogenic pellets [Fig. 3(A)], sug-
gesting that the process of chondrogenic induction increases TGFbRII
of both HGMCs and LGMCs but with a greater extent in LGMCs. This
result indicates that HGMCs are less responsive to chondrogenic
induction in the regulation of TGFbRII. Together with the result
shown in Fig. 2(A), this suggests that glucose concentration in
expansionculture can regulatehMSCs to alter their responsiveness to
chondrogenic induction through the modulation of TGFbRII, thus
affecting the activation of TGF-b signaling upon induction.
We further analyzed total and phosphorylated PKC in HGMCs
and LGMCs to determine the PKC activity of pre-differentiation
hMSCs. The result showed that PKC of HGMCs was increasingly
phosphorylated compared to that of LGMCs [Fig. 3(B)], which was
different from the PKC activity of cell pellets during chondrogenesis
shown in Fig. 2(B). These results suggest that the glucose concen-
tration in pre-differentiation culture medium modulates the
responsiveness of hMSCs to chondrogenic induction. To test
whether PKC is an upstream molecule regulating the expression of
TGFbRII, we treated HGMCs in expansion culture with the PKC
inhibitor, Gö6983, and analyzed the expression of TGFbRII. The
results showed that TGFbRII expression of HGMCs treated with the
PKC inhibitor was downregulated compared to that of the cells
without PKC inhibition [Fig. 3(C)], suggesting that glucose
concentration in pre-differentiation culture modulates the
expression of TGFbRII through the regulation of PKC activity.
Fig. 2. Analysis of TGF-b signaling molecules and PKC activity of hMSCs in chondrogenic cell pellets. A. Chondrogenic cell pellets composed of HGMCs and LGMCs were assayed using
western blotting to determine the expression of type II TGF-b receptor (TGFbRII), phospho-Smad3 (pSmad3), Smad3, and GAPDH as a loading control. A representative blot is shown.
Quantitative results based on densitometric measurements of blots are shown as the fold change relative to the group of HGMC pellets, and the mean of each group was calculated
based on samples of three independent experiments (n ¼ 3). B. The expression levels of phosphorylated PKC pan-isoform (pPKC) and PKC of HGMC and LGMC pellets were analyzed
with GAPDH as a loading control. A representative blot is shown. Quantitative results based on densitometric measurements of blots are shown as the fold change relative to the group
of HGMC pellets, and the mean of each group was calculated based on samples of three independent experiments (n ¼ 3). C. Illustration of the experimental setup depicts that HGMCs
and LGMCs were made into cell pellets and induced by high- and low-glucose chondrogenic medium, respectively, as a comparison study to the experiment illustrated in Fig. 1A. D.
The pPKC, PKC and TGFbRII expression of HGMC pellets induced by high-glucose chondrogenic medium (HG/HG) and that of LGMC pellets induced by low-glucose chondrogenic
medium (LG/LG) were analyzed 12 h after pellet creation using western blotting. A representative blot is shown. Quantitative results based on densitometric measurements of blots are
shown as the fold change relative to the group of HG/HG pellets, and the mean of each group was calculated based on samples of three independent experiments (n ¼ 3).
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in expansion culture medium to determine whether glucose
concentrations affect the amounts of endogenous TGF-b1 produc-
tion. ELISA results showed that the concentrations of active TGF-b1
ligands in both HGMC- and LGMC-conditioned media collected 15
or 30 min after fresh medium change were lower than 5 pg/mlFig. 3. Analysis of TGF-b receptorandPKCactivityofhMSCs inexpansionculture.A. Theexpress
determined bywesternblottingwithGAPDHas a loading control. A representativeblot is shown
change relative to thegroupofHGMCs/expansionculture, andthemeanofeachgroupwascalcul
and PKC of HGMCs and LGMCs in expansion culture was analyzed using western blotting. A re
blots are shownas the fold change relative to thegroupofHGMCs, and themeanof eachgroupw
ofpPKC, PKC, andTGFbRII ofHGMCs inexpansion culture treatedwith (þ) orwithout () thePKC
Quantitative results based on densitometricmeasurements of blots are shown as the fold chang
calculatedbasedonsamplesof three independentexperiments (n¼3).D. The concentrationof e
ELISA 15 and 30 min after fresh medium change. The meanwas calculated based on four repli[Fig. 3(D)], and those collected 1, 2, or 4 h after medium change
were undetectable, suggesting that glucose concentration does not
affect the production of endogenous TGF-b1 ligands. Moreover, our
study also showed that without the induction of TGF-b1, the mRNA
expression levels of cartilage-related markers of HGMC and LGMC
pellets were comparable during chondrogenesis (Fig. S2). TheseionofTGFbRII ofHGMCsandLGMCs inexpansion culture andchondrogenic cell pelletswas
. Quantitative results based ondensitometricmeasurements of blots are shownas the fold
atedbasedonsamplesof three independentexperiments (n¼3).B. TheexpressionofpPKC
presentative blot is shown. Quantitative results based on densitometric measurements of
as calculatedbasedonsamplesof three independentexperiments (n¼3).C. Theexpression
inhibitor,Gö6983,wasdeterminedusingwesternblotting.A representativeblot is shown.
e relative to the group of HGMCswithout PKC inhibition, and themean of each groupwas
ndogenousTGF-b1producedbyHGMCsorLGMCs inexpansionculturewasdeterminedby
cate samples (n ¼ 4) for each group.
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ligands are not involved in the regulation of glucose concentration
in expansion culture on hMSC chondrogenesis.
PKC inhibition in expansion culture upregulates the chondrogenic
capacity of hMSCs
Wefurther investigatedwhether themodulationofPKCactivityof
hMSCs using a PKC inhibitor during expansion culture regulates
subsequent chondrogenesis of cell pellets. HGMCs treated with or
without the PKC inhibitor for two passages expressed similar spindle
cell morphology and size [Fig. 4(A)]. No signiﬁcant difference in cell
proliferation was found between the two culture groups [Fig. 4(B)],
suggesting that PKC inhibition does not affect cell morphology and
proliferation. On the other hand, 12 h after chondrogenic induction,
cell pellets consisting of HGMCs previously treated with the PKC
inhibitor in expansion culture showed increased PKC phosphoryla-
tion and TGFbRII expression compared to those consisting of HGMCs
without PKC inhibition [Fig. 4(C)], suggesting that inhibition of PKC
activity inHGMCsduringpre-differentiationculture can increasePKC
activityandTGFbRII expressionof cell pellets duringchondrogenesis.
After 14 days of chondrogenesis, cell pellets consisting of
HGMCs previously treated with the PKC inhibitor in expansion
culture expressed signiﬁcantly higher levels of cartilage-related
markers, aggrecan and collagens type II and IX but a comparable
level of Sox9, compared to cell pellets consisting of HGMCs without
PKC inhibition [Fig. 4(D)]. This demonstrates that chondrogenesis of
HGMC pellets can be enhanced by inhibiting the PKC activity of
cells in expansion culture.
High-glucose culture upregulates the adipogenic capacity of hMSCs
through PKC activity
To investigate whether high-glucose culture promotes hMSCs to
differentiate into other cell lineages, we induced HGMCs and
LGMCs for osteogenesis and adipogenesis. After 21 days ofFig. 4. Chondrogenesis of HGMC pellets composed of hMSCs isolated from expansion cultu
high-glucose culture without the PKC inhibitor (HGMC), or with the PKC inhibitor (HGMC
inhibitor (HGMC þ I) was analyzed by quantifying the total DNA amounts at days 2, 4 and 7.
expression of pPKC, PKC, and TGFbRII of HGMC pellets and HGMC þ I pellets was determine
densitometric measurements of blots are shown as the fold change relative to the group of
independent experiments (n ¼ 3). D. Chondrogenesis of HGMC and HGMC þ I pellets was
determined using quantitative RTePCR and normalized to that of GAPDH. Comparisons are pr
those of HGMC pellets. The mean was calculated based on 4 replicate samples (n ¼ 4) forosteogenic induction, the results showed that themRNA expression
levels of bone-related markers, Cbfa1, alkaline phosphatase, and
osteocalcin, of HGMCs and LGMCs were comparable [Fig. 5(A)]. On
the other hand, mRNA levels of adipose-related markers, peroxi-
some proliferator-activated receptor gamma 2 and lipoprotein lipase
(LPL), of HGMCswere signiﬁcantly higher than those of LGMCs after
21 days of adipogenic induction [Fig. 5(B)], suggesting that high-
glucose expansion culture increases the adipogenic capacity of
hMSCs. Moreover, we also found that the mRNA expression level of
LPL of HGMCs treated with the PKC inhibitor during pre-
differentiation culture was signiﬁcantly downregulated during
adipogenesis, compared to those without PKC inhibition [Fig. 5(C)],
suggesting that PKC activity is associated with an upregulated
adipogenic capacity of HGMCs.Discussion
Our study demonstrates that hMSCs expanded in high-glucose
culture prior to differentiation show decreased chondrogenesis.
We also demonstrate that while chondrogenic induction upregu-
lates the expression of TGFbRII of hMSCs, high-glucose expansion
culture reduces the responsiveness of hMSCs to chondrogenic
induction, resulting in less TGFbRII on HGMCs than LGMCs and
thereby decreasing the activation of downstream signaling mole-
cules during chondrogenesis. Based on our ﬁndings, we propose
a molecular mechanism that illustrates how glucose concentration
in expansion culture regulates hMSCs to modulate PKC and TGFbRII
prior to and during chondrogenesis (Fig. 6).
The signiﬁcance of our ﬁndings is that glucose concentration in
expansion culture is capable of modulating the chondrogenic
capacity of hMSCs through regulation of PKC and TGFbRII before
chondrogenesis. Previous studies focused on studying the effect of
glucose concentration during the process of chondrogenesis. For
example, Han et al. demonstrated that high-glucose chondrogenic
culture promotes chondrogenesis of chick mesenchymal cells13,
and Mobasheri et al. found that high-glucose chondrogenic culturere with or without the PKC inhibitor, Gö6983. A. Micrographs of hMSCs maintained in
þ I). Scale bar: 500 mm. B. Proliferation of HGMCs and HGMCs treated with the PKC
The mean was calculated based on four replicate samples (n ¼ 4) for each group. C. The
d using western blotting. A representative blot is shown. Quantitative results based on
HGMC pellets, and the mean of each group was calculated based on samples of three
induced for 14 days. The mRNA transcript expression of Sox9, AGN, Col II, Col IX was
esented as fold change in the mRNA transcript levels of HGMC þ I pellets normalized to
each group.
Fig. 5. Osteogenesis and adipogenesis of HGMCs and LGMCs, and adipogenesis of HGMCs with PKC inhibition. A. The mRNA expression levels of Cbfa1, alkaline phosphatase (ALP),
and osteocalcin (OC) of HGMCs and LGMCs after 21 days of osteogenic induction. B. The mRNA expression levels of peroxisome proliferator-activated receptor gamma 2 (PPARg2) and
lipoprotein lipase (LPL) of HGMCs and LGMCs after 21 days of adipogenic induction. C. The mRNA expression levels of PPARg2 and LPL of HGMCs and PKC inhibitor-treated HGMCs
(HGMC þ I) after 14 days of adopogenic induction. The mRNA transcript expression of bone- and adipose-related markers was determined using quantitative RTePCR and
referenced to that of the control GAPDH. Data are presented as the fold change relative to the group of HGMCs. The meanwas calculated based on three replicate samples (n ¼ 3) for
each group.
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takes one step further to examine the effect of glucose concentra-
tion on MSCs in pre-differentiation culture and shows that glucose
concentration of the expansionmedium has a remarkable inﬂuence
on cell behavior and subsequent chondrogenesis. This ﬁnding
suggests that glucose concentration plays a critical role in priming
hMSCs during pre-differentiation culture for chondrogenesis upon
receiving induction signals. A previous study by Cramer et al. has
shown that chondrogenesis of hMSCs maintained in high-glucoseFig. 6. Diagram of the working model illustrating the effect of high-glucose pre-
differentiation culture on the regulation of PKC, TGFbRII, and TGF-b signaling mole-
cules of hMSC pellets during chondrogenesis. During ex vivo chondrogenesis in pellet
culture, hMSCs previously cultured with high-glucose medium in expansion culture
are less responsive to chondrogenic induction. The high-glucose exposure decreases
PKC activity, thus downregulating the expression of TGFbRII in cell pellets. The reduced
TGFbRII expression results in decreased TGF-b signaling upon the activation of TGF-
b ligand, further leading to reduced chondrogenesis.medium and subsequently induced in high-glucose culture is
downregulated compared to that of hMSCs maintained and
induced in low-glucose medium30, which is consistent with our
ﬁndings. Moreover, we identify the regulatory mechanism involved
in the glucose concentration-mediated modulation. Increasing
clinical research evidence has revealed that joint degeneration
diseases, such as osteoarthritis, may be associated with hypergly-
cemia31e35. Our ﬁnding that high-glucose expansion culture
decreases the chondrogenic capacity of hMSCs provides an in vitro
model to elucidate the mechanism of how hyperglycemia affects
hMSC chondrogenesis and the production of cartilaginous matrix,
thus leading to disrupted cartilage homeostasis observed in
osteoarthritis.
The extent of cell signaling stimulated by growth factors is
associated with the amount of available ligand receptors36. We
demonstrate that the amount of TGF-b receptors on hMSCs is
modulated by glucose concentration prior to chondrogenesis, thus
affecting the activation extent of TGF-b signaling molecules upon
induction. Our results also show that the modulation of TGF-
b receptor expression in expansion culture is not regulated by
endogenously produced TGF-b1 ligands. Thoughwe cannot rule out
the possibility that glucose stimulates hMSCs to produce endoge-
nous TGF-b1 ligands that bind to extracellular matrix after being
released, or to produce other TGF-b isoforms, it is evident that
soluble endogenous TGF-b1 ligands are not involved in the regu-
lation of TGF-b signaling.
We show that high-glucose culture increases the activity of PKC
and the amount of TGFbRII in hMSCs, consistent with previous
studies using different cell types26e28. We also identify the mech-
anism by which glucose concentration regulates TGFbRII of hMSCs
through the modulation of PKC activity to affect chondrogenesis.
Similarly, Ryu et al. have reported that high-glucose culture regu-
lates the TGF-b1 expression of hMSCs through the modulation of
T.-L. Tsai et al. / Osteoarthritis and Cartilage 21 (2013) 368e376 375PKC and several other signaling molecules37. It is known that high-
glucose culture has a global impact on cellular machinery. Thus, it is
possible that other mechanisms besides the PKC/TGF-b signaling
pathways are also involved in the chondrogenic regulation by high-
glucose medium. Nonetheless, since the TGF-b signaling pathways
is the dominant mechanism for chondrogenesis7,15e19, and PKC
activity is closely associated with glucose concentration38, this
study was designed to identify the role of the PKC/TGF-b signaling
pathways regulated by glucose concentration in the modulation of
hMSC chondrogenesis.
One of our interesting ﬁndings is that chondrogenic induction
upregulates the expression of TGFbRII of both HGMCs and LGMCs.
During chondrogenic induction, hMSCs are made into cell pellets
and induced in serum-free medium supplemented with TGF-b1.
Previous reports suggest that the expression of growth factor
receptors is differentially regulated in two-dimensional (2D) and
three-dimensional (3D) culture. For example, activation of
epidermal growth factor receptor II of human breast cancer cells
was greater in 3D culture than in 2D culture39, and the amount of
TGFbRII in microvascular endothelial cells is signiﬁcantly lower in
3D than 2D culture40. A previous study demonstrates that TGF-b1
induction or serum deprivation upregulates the expression of TGF-
b receptor41, suggesting the chemistry of chondrogenic medium
also contributes to the regulation of TGFbRII. However, the details
of how these factors work together to upregulate the expression of
TGFbRII in hMSCs are not clear, and should be the focus of further
investigation.
Our results demonstrate that while decreasing the chondro-
genic capacity of hMSCs, high-glucose expansion culture increases
the adipogenic capacity of the cells. Other research groups have
shown similar results using adipose tissue- or muscle-derived stem
cells11,30, suggesting that high-glucose culture drives hMSCs toward
the adipogenic lineage. Our results also show that suppressing the
PKC activity of HGMCs can reduce the upregulated adipogenesis
and increase the downregulated chondrogenesis, suggesting that
while losing the adipogenic potential, these cells regain their
chondrogenic potential. These ﬁndings together suggest that the
PKC activity of pre-differentiation hMSCs plays a critical role in
mediating other cellular activities associated with the commitment
of cell fates. Thus, it seems beneﬁcial to reduce PKC activity of
hMSCs in expansion culture before differentiation to enhance
subsequent chondrogenesis in cell pellets. Based on our ﬁndings,
we propose that treating hMSCs with a PKC inhibitor in expansion
culture may be a practical approach to prime hMSCs for enhancing
chondrogenesis.
In summary, we demonstrate that the chondrogenic capacity
of pre-differentiation hMSCs is modulated by glucose concen-
tration of medium in expansion culture through the regulation of
PKC activity and TGF-b receptor expression. Moreover, chon-
drogenesis induced in subsequent pellet culture can be enhanced
by modulating PKC activity of hMSCs before differentiation. Our
ﬁndings uncover the importance of maintaining low-glucose
concentration in both in vitro and in vivo environments to
support chondrogenesis of hMSCs, which can potentially beneﬁt
the research of cartilage tissue engineering and cartilage
diseases, such as osteoarthritis induced by hyperglycemic dis-
orders and offer a viable option to enhance hMSC chondro-
genesis using a pharmacological approach for cartilage regener-
ation applications.
Author contributions
T-L Tsai participated in the study design, carried out cell culture,
data collection, analysis and interpretation, and drafted the
manuscript.PA Manner harvested bone marrow, and participated in data
interpretation, and drafting the manuscript.
W-J Li designed the experiment, coordinated the study, inter-
preted data, and drafted the manuscript.Conﬂict of interest
None to declare.Supplementary data
Supplementary data related to this article can be found at http://
dx.doi.org/10.1016/j.joca.2012.11.001.References
1. Javazon EH, Beggs KJ, Flake AW. Mesenchymal stem cells:
paradoxes of passaging. Exp Hematol 2004;32:414e25.
2. Barry FP, Murphy JM. Mesenchymal stem cells: clinical appli-
cations and biological characterization. Int J Biochem Cell Biol
2004;36:568e84.
3. Jorgensen C, Gordeladze J, Noel D. Tissue engineering through
autologous mesenchymal stem cells. Curr Opin Biotechnol
2004;15:406e10.
4. Campagnoli C, Roberts IA, Kumar S, Bennett PR, Bellantuono I,
Fisk NM. Identiﬁcation of mesenchymal stem/progenitor cells
in human ﬁrst-trimester fetal blood, liver, and bone marrow.
Blood 2001;98:2396e402.
5. Erices A, Conget P, Minguell JJ. Mesenchymal progenitor cells
in human umbilical cord blood. Br J Haematol 2000;109:
235e42.
6. Kogler G, Sensken S, Airey JA, Trapp T, Muschen M,
Feldhahn N, et al. A new human somatic stem cell from
placental cord blood with intrinsic pluripotent differentiation
potential. J Exp Med 2004;200:123e35.
7. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R,
Mosca JD, et al. Multilineage potential of adult human
mesenchymal stem cells. Science 1999;284:143e7.
8. Alm JJ, Heino TJ, Hentunen TA, Vaananen HK, Aro HT. Transient
100 nM dexamethasone treatment reduces inter- and intra-
individual variations in osteoblastic differentiation of bone
marrow-derived human mesenchymal stem cells. Tissue Eng
Part C Methods 2012.
9. Xiao Y, Peperzak V, van Rijn L, Borst J, de Bruijn JD. Dexa-
methasone treatment during the expansion phase maintains
stemness of bone marrow mesenchymal stem cells. J Tissue
Eng Regen Med 2010;4:374e86.
10. Chuang CC, Yang RS, Tsai KS, Ho FM, Liu SH. Hyperglycemia
enhances adipogenic induction of lipid accumulation:
involvement of extracellular signal-regulated protein kinase
1/2, phosphoinositide 3-kinase/Akt, and peroxisome prolif-
erator-activated receptor gamma signaling. Endocrinology
2007;148:4267e75.
11. Aguiari P, Leo S, Zavan B, Vindigni V, Rimessi A, Bianchi K,
et al. High glucose induces adipogenic differentiation of
muscle-derived stem cells. Proc Natl Acad Sci U S A
2008;105:1226e31.
12. Li YM, Schilling T, Benisch P, Zeck S, Meissner-Weigl J,
Schneider D, et al. Effects of high glucose on mesenchymal
stem cell proliferation and differentiation. Biochem Biophys
Res Commun 2007;363:209e15.
13. Han YS, Bang OS, Jin EJ, Park JH, Sonn JK, Kang SS. High dose of
glucose promotes chondrogenesis via PKCalpha and MAPK
signaling pathways in chick mesenchymal cells. Cell Tissue Res
2004;318:571e8.
T.-L. Tsai et al. / Osteoarthritis and Cartilage 21 (2013) 368e37637614. Sotiropoulou PA, Perez SA, Salagianni M, Baxevanis CN,
Papamichail M. Characterization of the optimal culture
conditions for clinical scale production of human mesen-
chymal stem cells. Stem Cells 2006;24:462e71.
15. Bian L, Zhai DY, Tous E, Rai R, Mauck RL, Burdick JA. Enhanced
MSC chondrogenesis following delivery of TGF-beta3 from
alginate microspheres within hyaluronic acid hydrogels
in vitro and in vivo. Biomaterials 2011;32:6425e34.
16. Johnstone B, Hering TM, Caplan AI, Goldberg VM, Yoo JU.
In vitro chondrogenesis of bone marrow-derived mesen-
chymal progenitor cells. Exp Cell Res 1998;238:265e72.
17. Baddoo M, Hill K, Wilkinson R, Gaupp D, Hughes C, Kopen GC,
et al. Characterization of mesenchymal stem cells isolated from
murine bone marrow by negative selection. J Cell Biochem
2003;89:1235e49.
18. Sekiya I, Vuoristo JT, Larson BL, Prockop DJ. In vitro cartilage
formation by human adult stem cells from bone marrow
stroma deﬁnes the sequence of cellular and molecular events
during chondrogenesis. Proc Natl Acad Sci U S A 2002;99:
4397e402.
19. Caplan AI. Mesenchymal stem cells. J Orthop Res 1991;9:
641e50.
20. Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell
membrane to the nucleus. Cell 2003;113:685e700.
21. Feng XH, Derynck R. Speciﬁcity and versatility in tgf-beta
signaling through Smads. Annu Rev Cell Dev Biol 2005;21:
659e93.
22. Furumatsu T, Ozaki T, Asahara H. Smad3 activates the Sox9-
dependent transcription on chromatin. Int J Biochem Cell
Biol 2009;41:1198e204.
23. Furumatsu T, Tsuda M, Taniguchi N, Tajima Y, Asahara H.
Smad3 induces chondrogenesis through the activation of SOX9
via CREB-binding protein/p300 recruitment. J Biol Chem
2005;280:8343e50.
24. Palmer GD, Steinert A, Pascher A, Gouze E, Gouze JN, Betz O,
et al. Gene-induced chondrogenesis of primary mesenchymal
stem cells in vitro. Mol Ther 2005;12:219e28.
25. Wang WG, Lou SQ, Ju XD, Xia K, Xia JH. In vitro chondrogenesis
of human bone marrow-derived mesenchymal progenitor
cells in monolayer culture: activation by transfection with
TGF-beta2. Tissue Cell 2003;35:69e77.
26. Wu L, Derynck R. Essential role of TGF-beta signaling in
glucose-induced cell hypertrophy. Dev Cell 2009;17:35e48.
27. Yasuda Y, Nakamura J, Hamada Y, Nakayama M, Chaya S,
Naruse K, et al. Role of PKC and TGF-beta receptor in glucose-
induced proliferation of smooth muscle cells. Biochem Biophys
Res Commun 2001;281:71e7.
28. Lindschau C, Quass P, Menne J, Guler F, Fiebeler A, Leitges M,
et al. Glucose-induced TGF-beta1 and TGF-beta receptor-1
expression in vascular smooth muscle cells is mediated by
protein kinase C-alpha. Hypertension 2003;42:335e41.29. Mobasheri A, Vannucci SJ, Bondy CA, Carter SD, Innes JF,
Arteaga MF, et al. Glucose transport and metabolism in
chondrocytes: a key to understanding chondrogenesis, skel-
etal development and cartilage degradation in osteoarthritis.
Histol Histopathol 2002;17:1239e67.
30. Cramer C, Freisinger E, Jones RK, Slakey DP, Dupin CL,
Newsome ER, et al. Persistent high glucose concentrations
alter the regenerative potential of mesenchymal stem cells.
Stem Cells Dev 2010;19:1875e84.
31. Yoshimura N, Muraki S, Oka H, Kawaguchi H, Nakamura K,
Akune T. Association of knee osteoarthritis with the accumula-
tion of metabolic risk factors such as overweight, hypertension,
dyslipidemia, and impaired glucose tolerance in Japanese men
and women: the ROAD study. J Rheumatol 2011;38:921e30.
32. Davies-Tuck ML, Wang Y, Wluka AE, Berry PA, Giles GG,
English DR, et al. Increased fasting serum glucose concentra-
tion is associated with adverse knee structural changes in
adults with no knee symptoms and diabetes. Maturitas
2012;72:373e8.
33. Hart DJ, Doyle DV, Spector TD. Association between metabolic
factors and knee osteoarthritis in women: the Chingford
Study. J Rheumatol 1995;22:1118e23.
34. Sturmer T, Brenner H, Brenner RE, Gunther KP. Non-insulin
dependent diabetes mellitus (NIDDM) and patterns of osteo-
arthritis. The Ulm osteoarthritis study. Scand J Rheumatol
2001;30:169e71.
35. Arthritis as a potential barrier to physical activity among
adults with diabetes e United States, 2005 and 2007. MMWR
Morb Mortal Wkly Rep 2008;57:486e9.
36. Nanney LB, Paulsen S, Davidson MK, Cardwell NL, Whitsitt JS,
Davidson JM. Boosting epidermal growth factor receptor
expression by gene gun transfection stimulates epidermal
growth in vivo. Wound Repair Regen 2000;8:117e27.
37. Ryu JM, Lee MY, Yun SP, Han HJ. High glucose regulates cyclin
D1/E of human mesenchymal stem cells through TGF-beta1
expression via Ca2þ/PKC/MAPKs and PI3K/Akt/mTOR signal
pathways. J Cell Physiol 2010;224:59e70.
38. Lee TS, Saltsman KA, Ohashi H, King GL. Activation of protein
kinase C by elevation of glucose concentration: proposal for
a mechanism in the development of diabetic vascular
complications. Proc Natl Acad Sci U S A 1989;86:5141e5.
39. Pickl M, Ries CH. Comparison of 3D and 2D tumor models
reveals enhanced HER2 activation in 3D associated with an
increased response to trastuzumab. Oncogene 2009;28:461e8.
40. Sankar S, Mahooti-Brooks N, Bensen L, McCarthy TL,
Centrella M, Madri JA. Modulation of transforming growth
factor beta receptor levels on microvascular endothelial cells
during in vitro angiogenesis. J Clin Invest 1996;97:1436e46.
41. Kleeff J, Korc M. Up-regulation of transforming growth factor
(TGF)-beta receptors by TGF-beta1 in COLO-357 cells. J Biol
Chem 1998;273:7495e500.
